Planta Med 2005; 71(4): 295-299
DOI: 10.1055/s-2005-864093
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Antioxidant Effects of Diarylheptanoid Derivatives from Alnus japonica on Human LDL Oxidation

Woo Song Lee1 , 3 , Ju-Ryoung Kim1 , 3 , Kyung-Ran Im1 , Kyung-Hyun Cho1 , Dai-Eun Sok2 , Tae-Sook Jeong1
  • 1National Research Lab. of Lipid Metabolism & Atherosclerosis, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea
  • 2College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea
  • 3Both authors contributed equally to the work
Further Information

Publication History

Received: June 9, 2004

Accepted: October 26, 2004

Publication Date:
27 April 2005 (online)

Abstract

Two diarylheptanoids, oregonin (1) and hirsutanone (2), were isolated by bioassay-guided fractionation of the methanol extracts of the leaves of Alnus japonica Steud and their structures were elucidated from their spectroscopic data. Compounds 1 and 2 exhibited significant low-density lipoprotein (LDL)-antioxidant activities, e. g., thiobarbituric acid-reactive substances (TBARS) assay (1: IC50 = 3.2 μM, 2: IC50 = 1.5 μM), lag time (1 : 162 min, 2 : 230 min at 2.0 μM, control: 63 min), relative electrophoretic mobility (REM, inhibition of 1 : 71 %, 2 : 75 % at 10 μM), apoB-100 fragmentation (inhibition of 1 : 27.3 %, 2 : 40.3 % at 10 μM) and macrophage-mediated LDL oxidation (inhibition of 1 : 82 %, 2 : 84 % at 1 μM).

References

  • 1 Glass C K, Witzum J L. Atherosclerosis: the road ahead.  Cell. 2001;  104 503-16
  • 2 Liao L, Starzyk R M, Granger D N. Molecular determinants of oxidized low-density lipoprotein-induced leukocyte adhesion and microvascular dysfunction.  Arterioscler Thromb Vasc Biol. 1997;  17 437-44
  • 3 Dejager S, Mietus-Synder M, Pitas R E. Oxidized low-density lipoproteins bind to the scavenger receptor expressed by rabbit smooth muscle cells and macrophages.  Arterioscler Thromb. 1993;  13 371-8
  • 4 Parthasarathy S, Santanam N, Ramachandran S, Meilhac O. Oxidants and antioxidants in atherogenesis: an appraisal.  J Lipid Res. 1999;  40 2143-57
  • 5 Lee S J. Korea Folk Medicine. Seoul. Seoul National University Publishing Center Press 1996: p 40
  • 6 Lee M W, Kim J H, Jeong D W, Ahn K H, Toh S H, Surh Y J. Inhibition of cyclooxygenase-2 expression by diarylheptanoids from the bark of Alnus hirsuta var. sibirica .  Biol Pharm Bull. 2000;  23 517-8
  • 7 Lee M W, Kim N Y, Park M S, Ahn K H, Toh S H, Hahn D R. et al . Diarylheptanoids with in vitro inducible nitric oxide synthesis inhibitory activity from Alnus hirsuta .  Planta Medica. 2000;  66 551-3
  • 8 Keseru G M, Nogradi M. In: Studies in Natural Products Chemistry. Atta-ur-Rahman, Ed Elsevier Science New York; 1995 Vol 17: pp 357-68
  • 9 Joo S S, Kim H J, Kwon H S, Lee D I. Augmentation of macrophage antitumor activities and nitric oxide production by oregonin.  Arch Pharm Res. 2002;  25 457-62
  • 10 Ahn B T, Lee S K, Lee S B, Lee E S, Kim J G, Bok S H. et al . Low-density lipoprotein-antioxidant constituents of Saururus chinensis .  J Nat Prod. 2001;  64 1562-4
  • 11 Ohta S, Aoki T, Hirata T, Suga T J. The structures of four diarylheptanoid glycosides from the female flowers of Alnus serrulatoides . J Chem Soc Perkin Trans 1 1984: 1635-42
  • 12 Karchesy J J, Laver M L, Barofsky D F, Barofsky E. Structure of oregonin, a natural diarylheptanoid xyloside. J Chem Soc Chem Commun 1974: 649-50
  • 13 Lee M W, Tanaka T, Nonaka G I, Nishioka I. Hirsunin, an ellagitannin with a diarylheptanoid moiety, from Alnus hirsuta var. microphylla .  Phytochemistry. 1992;  31 967-70
  • 14 Chapman M J, Goldstein S, Lagrange D, Laplaud P M. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.  J Lid Res. 1981;  22 339-58
  • 15 Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein.  Free Radic Res Commun. 1989;  6 67-75
  • 16 Jeong T S, Kim K S, Kim J R, Cho K H, Lee S, Lee W S. Novel 3,5-diarylpyrazolines and pyrazole as low-density lipoprotein oxidation inhibitor.  Bioorg Med Chem Lett. 2004;  14 2719-23
  • 17 Philippe L, Christiane D, Laure P, Martine M, Sabine G, Brudi M. et al . Impact of a combination of a calcium antagonist and a β-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophage and murine J774 cells.  Arterioscler Thromb Vasc Biol. 1997;  17 979-88
  • 18 Reid V C, Mitchinson M J. Toxicity of oxidized low-density lipoprotein towards mouse peritoneal macrophages in vitro .  Atherosclerosis. 1993;  98 17-24
  • 19 Miura S, Watanabe J, Tomita T, Sano M, Tomita I. The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+-mediated oxidative modification of low density lipoprotein.  Biol Pharm Bull. 1994;  17 1567-72
  • 20 Khursheed P N, Enrique B, Charles S L. Dilinoleoylphosphatidylcholine protects human low-density lipoproteins against oxidation.  Atherosclerosis. 2000;  152 89-95

Tae-Sook Jeong, Ph. D.

National Research Laboratory of Lipid Metabolism & Atherosclerosis

Korea Research Institute of Bioscience and Biotechnology

52 Oun-Dong

Yusong

Daejeon 305-333

Republic of Korea

Phone: +82-42-860-4558

Fax: +82-42-861-2675

Email: tsjeong@kribb.re.kr